↓ Skip to main content

Dove Medical Press

Development of oral immunomodulatory agents in the management of multiple sclerosis

Overview of attention for article published in Drug Design, Development and Therapy, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
22 patents

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
100 Mendeley
Title
Development of oral immunomodulatory agents in the management of multiple sclerosis
Published in
Drug Design, Development and Therapy, May 2011
DOI 10.2147/dddt.s10498
Pubmed ID
Authors

Richard Nicholas, Paolo Giannetti, Ali Alsanousi, Tim Friede, Paolo A Muraro

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
United States 1 1%
Uruguay 1 1%
Unknown 96 96%

Demographic breakdown

Readers by professional status Count As %
Other 17 17%
Student > Master 17 17%
Researcher 15 15%
Student > Bachelor 10 10%
Student > Ph. D. Student 6 6%
Other 16 16%
Unknown 19 19%
Readers by discipline Count As %
Medicine and Dentistry 39 39%
Neuroscience 9 9%
Agricultural and Biological Sciences 9 9%
Nursing and Health Professions 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 13 13%
Unknown 21 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#1,761,752
of 25,411,814 outputs
Outputs from Drug Design, Development and Therapy
#79
of 2,271 outputs
Outputs of similar age
#7,424
of 121,586 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 7 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,586 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.